Reactome | X17-445-103 Trial Group, -

Schema > Person > Entries

created	[InstanceEdit:9773716] D'Eustachio, Peter, 2022-05-09
dbId	9773727
displayName	X17-445-103 Trial Group, -
initial	-
modified	[InstanceEdit:9773733] D'Eustachio, Peter, 2022-05-09
publications	[LiteratureReference:9700232] Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial
schemaClass	Person
surname	X17-445-103 Trial Group

Cite Us!